Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 19, Number 12—December 2013

Guillain-Barré Syndrome Surveillance during National Influenza Vaccination Campaign, New York, USA, 2009

Gregory P. Giambrone1Comments to Author , Shelley M. Zansky, Millicent Eidson, Pamela G. Duncan, Louise-Anne McNutt, and Guthrie S. Birkhead
Author affiliations: New York State Department of Health, Albany, New York, USA (G.P. Giambrone, S.M. Zansky, M. Eidson, P.G. Duncan, G.S. Birkhead); University at Albany School of Public Health, Rensselaer, New York, USA (L.-A. McNutt, G.S. Birkhead)

Main Article

Table 2

Use of primary and secondary diagnosis codes for GBS identified by SPARCS, New York State Department of Health GBS surveillance system, 2009–2010*

Total cases reported
Confirmed/probable cases, no. (%)
Primary 149 116 (78)
Secondary 70 14 (20)
Total 219 130 (59)

*GBS, Guillain-Barré syndrome; SPARCS, Statewide Planning and Research Cooperative System. SPARCS collects administrative data on all hospital discharges in state facilities.

Main Article

1Current affiliation: Weill Cornell Medical College, New York, New York, USA.

Page created: November 19, 2013
Page updated: November 19, 2013
Page reviewed: November 19, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.